Blog | Sarah Cannon

Survivorship from a Cancer Survivor

September 14, 2018

In 2005, Jeff was diagnosed with stage IV non-Hodgkin lymphoma. After several rounds of chemotherapy, Jeff’s cancer went into remission; however...

Sarah Cannon

Ask The Expert: What is CAR T-Cell Therapy?

July 3, 2018

Fred LeMaistre, MD, Senior Vice President of Sarah Cannon Market Operations and Physician-in-Chief of Blood Cancers, discusses CAR T-Cell therapy...

Sarah Cannon

Why You Should Register to Donate Bone Marrow ...

April 12, 2017

HLA markers used in matching are inherited. Some ethnic groups have more complex tissue types than others, so a personÕs best chance of matching...

Sarah Cannon

What is Myeloma?

March 27, 2017

Myeloma is one of the three most common types of blood cancer, along with leukemia and lymphoma. Myeloma is a type of cancer that begins in the...

Sarah Cannon

The Impact of Blood Donation

September 30, 2016

It is estimated that more than 44,000 blood donations are needed every day in the United States, some of which are given to cancer patients as...

Sarah Cannon

Answers to Your Questions about ET

September 29, 2016

Although the cause of ET is unknown, researchers have found that approximately half of those living with ET have a specific genetic mutation ...

Sarah Cannon

Back to the Basics: Blood Cancer

September 28, 2016

September is Blood Cancer Awareness Month. What are the common types of blood cancer? What are the common treatments? Learn more about the three...

Sarah Cannon

Seven Blood Cancer Survivorship Tips

September 27, 2016

The blood cancer journey continues beyond recovery. The endurance, strength and perseverance you have demonstrated through your treatment will...

Sarah Cannon

Managing Myelofibrosis

September 14, 2016

Myelofibrosis (MF), is a type of myeloproliferative neoplasm (MPN), which is a type of blood cancer. Myelofibrosis is a rare blood cancer that...

Sarah Cannon

The Latest Developments in Blood Cancer Treatment

September 12, 2016

If you or a loved one has been diagnosed with a blood cancer, you may be wondering what the latest advancements are for this type of cancer. ...

Sarah Cannon

"Watchful Waiting"... What Is It?

September 7, 2016

Research has shown that for patients with chronic lymphocytic leukemia (CLL), whose disease is not acting aggressively, immediate treatment is...

Sarah Cannon

Frequently Asked Questions About Hematology Lab...

September 1, 2016

During your blood cancer journey, your hematologist/oncologist may require that you complete blood tests throughout your treatment. What are ...

Sarah Cannon

What is Polycythemia Vera or PV?

September 1, 2016

During Blood Cancer Awareness Month, it is important to educate yourself and your loved ones on all types of blood cancers, and share resources...

Sarah Cannon

Signs, Symptoms and Treatments for Childhood Blood...

July 30, 2016

September is not only Blood Cancer Awareness Month but also Childhood Cancer Awareness Month. As we wrap up this important month of awareness...

Sarah Cannon

Sarah Cannon Blood Cancer Research

December 3, 2015

Across the Sarah Cannon Blood Cancer Network, we are conducting clinical trials to advance therapies for those facing blood cancer.

Sarah Cannon

Myeloma: The Latest Developments and Research

March 31, 2015

March is Myeloma Awareness Month, created by the International Myeloma Foundation (IMF) to bring more attention to this rare blood and marrow...